Nicklas Westerholm
Chief Executive Officer at EGETIS THERAPEUTICS AB
Net worth: 123 465 $ as of 2024-03-30
Profile
Mr. Nicklas Westerholm is an Independent Director at Spago Nanomedical AB, a Chief Executive Officer at Egetis Therapeutics AB and a Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB.
He is on the Board of Directors at Spago Nanomedical AB.
Mr. Westerholm was previously employed as a Vice President by AstraZeneca AB and an Investor Relations Contact by AstraZeneca PLC.
He received his undergraduate degree from the University of Stockholm and an undergraduate degree from Royal Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB
0.07% | 2022-12-30 | 197,629 ( 0.07% ) | 123 465 $ | 2024-03-30 |
Nicklas Westerholm active positions
| Companies | Position | Start |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Executive Officer | 2017-06-15 |
| SPAGO NANOMEDICAL AB | Director/Board Member | 2019-05-07 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Former positions of Nicklas Westerholm
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 2017-05-31 |
| ASTRAZENECA PLC | Investor Relations Contact | 2011-09-07 |
Training of Nicklas Westerholm
| University of Stockholm | Undergraduate Degree |
| Royal Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Private companies | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Nicklas Westerholm
